1 Day
Source:
الدستور
New Approach: Weekly Insulin Injections
Recent trials have shown that the weekly insulin injection "Insulin Efficutura Alpha" or "Onsuwick," manufactured by Eli Lilly, is effective in managing blood sugar levels in patients with type 2 diabetes, as an alternative to the traditional daily injections. This new treatment—a long-acting version of insulin—is particularly beneficial for patients who have difficulty administering injections themselves or require assistance, especially the elderly and those with limited mobility or poor eyesight. The experiments demonstrated that this therapy maintains blood sugar levels comparable to daily treatment and has been rated as offering good value for money by the UK National Institute for Health and Care Excellence (NICE). However, plans for widespread availability within the UK have not yet been announced. This development aims to improve the quality of life for diabetic patients and make disease management easier, while emphasizing the importance of providing necessary support and guidance to ensure correct and equitable use of the treatment.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)